可孚医疗 01187Prospectus Information

Prospectus Information
返回 Stock Info Prospectus Allotment Results Allotment Profile Expected Lots
IPO Timeline
Broker Deadline
2026-04-30
Morning deadline
HKEX Deadline
2026-04-30
Noon deadline
Broker Results (T-2)
2026-05-04
Some brokers release in afternoon
Grey Market (T-1)
2026-05-05
Afternoon
HKEX Allotment (T-1)
2026-05-05
Evening
Registrar Allotment (T-1)
2026-05-05
Evening
Listing Day (T)
2026-05-06
First day of trading
Cross-Market Price Comparison
Other Listed Market Shenzhen (SZSE) — 可孚医疗
Other Market Stock Code301087
H-Share Offer PriceHK$ 39.33
Other Market PriceLoading...
Reference Exchange RateLoading...
H-Share Offer Price Premium/Discount vs Other MarketLoading...
Company Overview
Stock Name可孚医疗
Stock Code01187
Company Full Name可孚医疗
IndustryRobotics
Principal Activitiesprovider of home care medical devices in China
Listing Date2026-05-06
Listing Rules EraNew Rules (after Aug 2025)
Listing Rules ChapterTo be extracted
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)Yuhua District Changsha City, Hunan Province PRC
Business Address (Hong Kong)Unit B, 22/F, Mai Luen Industrial Building 23-31 Kung Yip Street Kwai Chung, New Territories Hong Kong
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttps://www.cofoe.com.cn/
Share Registrar卓佳证券登记有限公司 (Tricor Investor Services Limited)
Registrar Contact(852)2980 1333
A-Share/US Dual ListingNo
Offering Information
Offering Mechanism Mechanism B
Offer PriceHK$ 39.33 / shares
Offer Price RangeFinal offer price only, no range
Lot SizeTo be extracted
Entry ThresholdTo be extracted
Par ValueTo be extracted
Offer Period2026-04-27 to 2026-04-30
Global Offering SharesTo be extracted
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)No
Stabilizing Manager (Greenshoe)—
Cornerstone Share35.7%
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeHK$ 106,191,000
Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 100 HK$ 3,933
2 lots 200 HK$ 7,866
3 lots 300 HK$ 11,799
4 lots 400 HK$ 15,732
5 lots 500 HK$ 19,665
6 lots 600 HK$ 23,598
7 lots 700 HK$ 27,531
8 lots 800 HK$ 31,464
9 lots 900 HK$ 35,397
10 lots 1,000 HK$ 39,330
15 lots 1,500 HK$ 58,995
20 lots 2,000 HK$ 78,660
25 lots 2,500 HK$ 98,325
30 lots 3,000 HK$ 117,990
35 lots 3,500 HK$ 137,655
40 lots 4,000 HK$ 157,320
45 lots 4,500 HK$ 176,985
50 lots 5,000 HK$ 196,650
60 lots 6,000 HK$ 235,980
70 lots 7,000 HK$ 275,310
80 lots 8,000 HK$ 314,640
90 lots 9,000 HK$ 353,970
100 lots 10,000 HK$ 393,300
200 lots 20,000 HK$ 786,600
300 lots 30,000 HK$ 1,179,900
400 lots 40,000 HK$ 1,573,200
500 lots 50,000 HK$ 1,966,500
600 lots 60,000 HK$ 2,359,800
700 lots 70,000 HK$ 2,753,100
800 lots 80,000 HK$ 3,146,400
900 lots 90,000 HK$ 3,539,700
1,000 lots 100,000 HK$ 3,933,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
2,000 lots 200,000 HK$ 7,866,000
3,000 lots 300,000 HK$ 11,799,000
4,000 lots 400,000 HK$ 15,732,000
5,000 lots 500,000 HK$ 19,665,000
6,000 lots 600,000 HK$ 23,598,000
7,000 lots 700,000 HK$ 27,531,000
8,000 lots 800,000 HK$ 31,464,000
9,000 lots 900,000 HK$ 35,397,000
10,000 lots 1,000,000 HK$ 39,330,000
13,500 lots 1,350,000 HK$ 53,095,500
Valuation & Financials
Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)To be extracted
P/E RatioTo be extracted
Profit/Loss StatusTo be extracted
Period-End Cash BalanceTo be extracted
Listing ExpensesTo be extracted
Listing Expenses / Funds RaisedTo be extracted
Total Pre-IPO InvestmentTo be extracted
First Day Performance
First Day CloseHK$ 38.9
First Day OpenHK$ 39.84
First Day Change-1.09%
First Day Volume11185500.0
First Day Turnover428006000.0
Use of Proceeds
Use of Proceeds1、30.0%或約302.1百萬港元將用于全球拓展； 2、30.0%或約302.1百萬港元將用于持續的產品研發及技術創新，包括人工智能及物聯網應用； 3、20.0%或約201.4百萬港元將用于拓展國內銷售渠道及經銷網絡； 4、10.0%或約100.7百萬港元將用于品牌推廣及營銷活動； 5、10.0%或約100.7百萬港元將用于營運資金及一般公司用途。
Underwriting Syndicate
Joint Sponsors (2)
华泰金融控股（香港）有限公司 CE AOK809 法国巴黎证券（亚洲）有限公司 CE AAF669
Overall Coordinators (3)
华泰金融控股（香港）有限公司 CE AOK809 法国巴黎证券（亚洲）有限公司 CE AAF669 富途证券国际（香港）有限公司 CE AZT137
Joint Bookrunners (3)
华泰金融控股（香港）有限公司 CE AOK809 法国巴黎证券（亚洲）有限公司 CE AAF669 富途证券国际（香港）有限公司 CE AZT137
Joint Lead Managers (3)
华泰金融控股（香港）有限公司 CE AOK809 法国巴黎证券（亚洲）有限公司 CE AAF669 富途证券国际（香港）有限公司 CE AZT137
Cornerstone Investors
#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 FR M CONSULTING CO., LTD 23,487,876 HKD — 2.21% — 6 months 2026-11-06
2 ODI TRUST LIMITED 7,826,670 HKD — 0.74% — 6 months 2026-11-06
3 长沙雨丰科技有限公司 54,696,231 HKD — 5.15% — 6 months 2026-11-06
4 大成国际资产管理有限公司 15,657,273 HKD — 1.47% — 6 months 2026-11-06
5 戴钧安 19,574,541 HKD — 1.84% — 6 months 2026-11-06
6 黄雪林 39,149,082 HKD — 3.69% — 6 months 2026-11-06
7 蓝思科技(香港)有限公司 78,302,097 HKD — 7.37% — 6 months 2026-11-06
8 陆勤超 15,657,273 HKD — 1.47% — 6 months 2026-11-06
9 盘京港景投资基金 39,149,082 HKD — 3.69% — 6 months 2026-11-06
10 香港汉清达实业有限公司 19,574,541 HKD — 1.84% — 6 months 2026-11-06
11 远信投资及中国银河国际投资 50,971,680 HKD — 4.80% — 6 months 2026-11-06
12 中康科技控股有限公司 15,657,273 HKD — 1.47% — 6 months 2026-11-06
Directors & Management
ChairmanMr. Zhang Min
Company Secretary薛小橋,夏正靜
No director data available.
Major Shareholders
Major Shareholders & HoldingsSUBSTANTIAL SHAREHOLDERS So far as our Directors are aware, immediately following the completion of the Global Offering and without taking into account any A Shares to be issued upon exercise of the share options granted under the Employee Incentive Schemes, the following p
AI AI Analysis
!
The following content is generated by an AI model based on historical IPO data. It does NOT constitute investment advice, solicitation, or recommendation. Past subscription patterns and post-listing performance do not guarantee future results. Data may contain inaccuracies — always verify against official HKEX filings and prospectuses before making any investment decision.

Market Sentiment

The IPO drew intense retail interest with an oversubscription ratio of 399.08 times, signaling robust demand. However, the recorded hit rate of 0% — likely due to a full reallocation of the public tranche to the placing under the '机械B-无回补' mechanism — meant no public allocations were made, a highly atypical outcome. This divergence suggests that despite the enthusiasm, the allocation structure strongly favored institutional investors. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

The tier distribution reveals an unusual quirk: the 甲尾 (A-tail) group expected only 0.85 lots per application, while the 乙头 (B-head) group received a full 1.0 lot. This creates a perverse incentive where a larger B-head bid actually improved allocation efficiency over the highest A-tier, likely due to 'loose lot' rounding effects at the A/B boundary. The anomaly erodes the typical premium of smaller applications and warrants careful review of broker handling. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Demographics

Mainland Chinese investors made up 65.6% of applicants, underscoring strong cross-border appetite for this Hong Kong robotics IPO. Men accounted for 64.9% and the average age was 41.4, reflecting a predominantly middle-aged male investor profile common in tech-focused offerings. This demographic skew may impact aftermarket liquidity and sentiment dynamics. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

AI-generated content. For informational purposes only. Not financial advice. Verify against official sources.
Subscription Tiers
IPO Timeline
Disclaimer & Risk Warning

Site Nature: This website (cibo.qizai.ai) is an independent technology product showcase platform established by Panda Securities Limited (CE Number: BNC380). This website itself and all content displayed herein do not constitute and are not involved in any regulated activity or licensed service.

Not Investment Advice: The data on this page is automatically extracted from prospectus PDFs by AI and may contain omissions or errors. All information and data on this page are sourced from prospectuses and related historical documents, are not real-time data, and will not be automatically updated, reflecting historical information at the time of prospectus publication. All content is provided solely for AI tool analysis learning exchange and technical reference purposes, and absolutely does not constitute any investment advice, offer to buy or sell, solicitation, recommendation, or guarantee. The output of this AI analysis tool should not be interpreted as investment opinion.

Decision Responsibility: Users should make investment decisions based on their own independent judgment and consult independent licensed financial advisors when needed. Neither the Company nor this AI analysis tool shall bear any responsibility for any investment decisions made by users based on the information on this page.

Separation from Panda Securities Official Website: The content of this website is strictly distinct from the SFC-regulated licensed services provided by Panda Securities' official website (fafa.hk). No securities trading or account opening or other regulated operations can be conducted through this website.

Panda Securities Limited is a licensed corporation regulated by the Hong Kong SFC (CE Number: BNC380) and a Hong Kong Exchange Participant (Participant ID: 02229). Use of this website constitutes acceptance of this disclaimer.

Cibo — IPO & Market Data Analytics